Oppenheimer Raises TransMedics Group (NASDAQ:TMDX) Price Target to $200.00
TransMedics Group (NASDAQ:TMDX – Free Report) had its target price boosted by Oppenheimer from $125.00 to $200.00 in a research note issued to investors on Thursday, Benzinga reports. The firm currently has an outperform rating on the stock. A number of other equities analysts have also issued reports on the stock. Piper Sandler increased their […]
More Stories
Trump Warns ‘Biggest Threat’ to US Would Be Supreme Court Overruling Tariffs
By Jack Phillips President Donald Trump on Tuesday said that national security could be at risk if the Supreme Court...
Federal Reserve Poised to Cut Interest Rates at Final Meeting of 2025
By Andrew Moran The Federal Reserve’s final policy meeting of the year is expected to end with an interest rate...
Will Japanese Series, The Fragrant Flower Blooms With Dignity, Return for Season 2?
The Japanese animated drama, The Fragrant Flower Blooms With Dignity, is getting praised by many viewers from around the world....
6 Best Analytics Agencies in 2026 to Level Up Your Data Strategy
What do businesses do? Build and innovate from raw and scratch, right? But creation generates its own new raw material,...
Dalton Gomez Net Worth: How Rich Is Ariana Grande’s Ex-Husband?
He became popular following his affair with Ariana Grande. Even before he got into a relationship with Ariana, he was...
Trump Admin Aims to Create Family-Friendly Airports With Healthier Foods, Exercise Areas
By Jill McLaughlin The Trump administration is ready to spend $1 billion to create healthier food options, private breastfeeding pods,...